113 related articles for article (PubMed ID: 31662500)
1. Amelioration of Mucositis in Proton Therapy of Fanconi Anemia Fanca
Quinn TJ; Ding X; Li X; Wilson GD; Buelow K; Sivananthan A; Thermozier S; Henderson A; Epperly MW; Franicola D; Wipf P; Greenberger JS; Stevens CW; Kabolizadeh P
In Vivo; 2019; 33(6):1757-1766. PubMed ID: 31662500
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of Head and Neck Radiation-Induced Mucositis and Distant Marrow Suppression in Fanca
Willis J; Epperly MW; Fisher R; Zhang X; Shields D; Hou W; Wang H; Li S; Wipf P; Parmar K; Guinan E; Steinman J; Greenberger JS
Radiat Res; 2018 Jun; 189(6):560-578. PubMed ID: 29584588
[TBL] [Abstract][Full Text] [Related]
3. Fanconi Anemia Mouse Genotype-specific Mitigation of Total Body Irradiation by GS-Nitroxide JP4-039.
Epperly MW; Fisher R; Zhang X; Hou W; Shields D; Wipf P; Wang H; Thermozier S; Greenberger JS
In Vivo; 2020; 34(1):33-38. PubMed ID: 31882460
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.
Berhane H; Shinde A; Kalash R; Xu K; Epperly MW; Goff J; Franicola D; Zhang X; Dixon T; Shields D; Wang H; Wipf P; Li S; Gao X; Greenberger JS
Radiat Res; 2014 Jul; 182(1):35-49. PubMed ID: 24932534
[TBL] [Abstract][Full Text] [Related]
5. Continuous One Year Oral Administration of the Radiation Mitigator, MMS350, after Total-Body Irradiation, Restores Bone Marrow Stromal Cell Proliferative Capacity and Reduces Senescence in Fanconi Anemia (Fanca
Sivananthan A; Shields D; Fisher R; Hou W; Zhang X; Franicola D; Epperly MW; Wipf P; Greenberger JS
Radiat Res; 2019 Feb; 191(2):139-153. PubMed ID: 30499383
[TBL] [Abstract][Full Text] [Related]
6. Induction of TGF-β by Irradiation or Chemotherapy in Fanconi Anemia (FA) Mouse Bone Marrow Is Modulated by Small Molecule Radiation Mitigators JP4-039 and MMS350.
Epperly MW; Rhieu BH; Franicola D; Dixon T; Cao S; Zhang X; Shields D; Wang H; Wipf P; Greenberger JS
In Vivo; 2017; 31(2):159-168. PubMed ID: 28358695
[TBL] [Abstract][Full Text] [Related]
7. Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.
Berhane H; Epperly MW; Goff J; Kalash R; Cao S; Franicola D; Zhang X; Shields D; Houghton F; Wang H; Wipf P; Parmar K; Greenberger JS
Radiat Res; 2014 Jan; 181(1):76-89. PubMed ID: 24397476
[TBL] [Abstract][Full Text] [Related]
8. GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.
Bernard ME; Kim H; Berhane H; Epperly MW; Franicola D; Zhang X; Houghton F; Shields D; Wang H; Bakkenist CJ; Frantz MC; Forbeck EM; Goff JP; Wipf P; Greenberger JS
Radiat Res; 2011 Nov; 176(5):603-12. PubMed ID: 21939290
[TBL] [Abstract][Full Text] [Related]
9. Improved hematopoiesis in GS-nitroxide (JP4-039)-treated mouse long-term bone marrow cultures and radioresistance of derived bone marrow stromal cell lines.
Shinde A; Epperly MW; Cao S; Holt D; Goff J; Shields D; Franicola D; Wipf P; Wang H; Greenberger JS
In Vivo; 2014; 28(5):699-708. PubMed ID: 25189880
[TBL] [Abstract][Full Text] [Related]
10. Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice.
Shinde A; Berhane H; Rhieu BH; Kalash R; Xu K; Goff J; Epperly MW; Franicola D; Zhang X; Dixon T; Shields D; Wang H; Wipf P; Parmar K; Guinan E; Kagan V; Tyurin V; Ferris RL; Zhang X; Li S; Greenberger JS
Radiat Res; 2016 Feb; 185(2):134-50. PubMed ID: 26789701
[TBL] [Abstract][Full Text] [Related]
11. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
12. Radiobiologic effects of GS-nitroxide (JP4-039) on the hematopoietic syndrome.
Goff JP; Epperly MW; Dixon T; Wang H; Franicola D; Shields D; Wipf P; Li S; Gao X; Greenberger JS
In Vivo; 2011; 25(3):315-23. PubMed ID: 21576404
[TBL] [Abstract][Full Text] [Related]
13. Chemical Carcinogen (Dimethyl-benzanthracene) Induced Transplantable Cancer in Fanconi Anemia (Fanca-/-) Mice.
Epperly MW; Mukherjee A; Fisher R; Shields D; Hou W; Wang H; Rigatti LH; Green A; Huq MS; Greenberger JS
In Vivo; 2023; 37(6):2421-2432. PubMed ID: 37905617
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Analogs of the GS-Nitroxide, JP4-039, as Total Body Irradiation Mitigators.
Epperly MW; Sacher JR; Krainz T; Zhang X; Wipf P; Liang M; Fisher R; Li S; Wang H; Greenberger JS
In Vivo; 2017 Jan; 31(1):39-43. PubMed ID: 28064218
[TBL] [Abstract][Full Text] [Related]
15. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of radiation esophagitis by orally administered p53/Mdm2/Mdm4 inhibitor (BEB55) or GS-nitroxide.
Kim H; Bernard ME; Epperly MW; Shen H; Amoscato A; Dixon TM; Doemling AS; Li S; Gao X; Wipf P; Wang H; Zhang X; Kagan VE; Greenberger JS
In Vivo; 2011; 25(6):841-8. PubMed ID: 22021675
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
18. [Construction of FANCA mutant protein from Fanconi anemia patient and analysis of its function].
Chen F; Zhang KJ; Zuo XL; Zeng XC
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):741-4. PubMed ID: 18457264
[TBL] [Abstract][Full Text] [Related]
19. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
[TBL] [Abstract][Full Text] [Related]
20. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
